_2020091018165303jzv.jpg "Decoding The World Of ETF")
My Account
Partnered by:
Associate Partners:
Partnered by:
Associate Partners:
Jan 18, 2021 10:52 PM IST Net Sales are expected to increase by 5.3 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 3,638.1 crore, according to Prabhudas Lilladher.
Oct 14, 2019 03:49 PM IST Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.
Jul 12, 2019 04:33 PM IST Net Sales are expected to increase by 13.9 percent Y-o-Y (down 11.7 percent Q-o-Q) to Rs. 3,296.1 crore, according to Prabhudas Lilladher.
Apr 12, 2019 12:52 PM IST Net Sales are expected to decrease by 3.6 percent Y-o-Y (down 12.4 percent Q-o-Q) to Rs. 3,134.8 crore, according to Prabhudas Lilladher.
Jan 18, 2019 01:53 PM IST Net Sales are expected to decrease by 6.7 percent Y-o-Y (up 2.8 percent Q-o-Q) to Rs. 3,043 crore, according to Sharekhan.
Jan 11, 2019 05:28 PM IST Net Sales are expected to decrease by 1.1 percent Y-o-Y (up 8.8 percent Q-o-Q) to Rs. 3,222.2 crore, according to ICICI Direct.
Jan 04, 2019 10:45 AM IST For Lupin, Credit Suisse sees margin improving but weak Tamiflu season could be an overhang.
Oct 17, 2018 05:55 PM IST Net Sales are expected to decrease by 5.2 percent Y-o-Y (up 5.9 percent Q-o-Q) to Rs. 3,070 crore, according to HDFC Securities.
Oct 16, 2018 06:57 PM IST Net Sales are expected to decrease by 4.4 percent Y-o-Y (up 8.1 percent Q-o-Q) to Rs. 3,093 crore, according to Sharekhan.
Oct 12, 2018 04:30 PM IST Net Sales are expected to decrease by 7.6 percent Y-o-Y (up 3.2 percent Q-o-Q) to Rs. 2,986.6 crore, according to ICICI Direct.
Jul 12, 2018 09:42 PM IST "For the first time after six consecutive quarters, the pharma companies under our coverage will report double digit YoY growth of 13 percent in revenues,” said HDFC Securities
May 09, 2018 08:46 AM IST Global brokerage houses have upgraded a few stocks, highlighting robust Q4 FY18 results. Moneycontrol takes a look at six such stocks which have seen a ratings upgrade
Apr 20, 2018 12:52 PM IST Net Sales are expected to increase by 24 percent Y-o-Y (down 5.7 percent Q-o-Q) to Rs. 3,070 crore, according to HDFC Securities.
Apr 16, 2018 06:01 PM IST Net Sales are expected to increase by 27.7 percent Y-o-Y (down 2.9 percent Q-o-Q) to Rs. 3,163.5 crore, according to Edelweiss.
Apr 12, 2018 05:53 PM IST Analysts predict the last quarter of FY18 to be mixed bag with revenues expected to remain almost flat to a growth of lower single digit on year-on-year basis. The net profit is predicted to decline by around 9-10 percent.
Jan 18, 2018 08:36 AM IST As Indian drug makers brace up to report their third quarter earnings in the days ahead, analysts predict Q3 FY18 to be mixed bag with revenues expected to remain flat on year-on-year basis, though on sequential basis things may look much better.
Jan 11, 2018 04:06 PM IST The USFDA granted 246 nods in Q3FY18, which is the highest-ever approvals in a single quarter. Cadila Healthcare received 23 and Aurobindo Pharma got 18 approvals.
Apr 17, 2017 01:13 PM IST Net Sales are expected to increase by 5.8 percent Q-o-Q (down 0.4 percent Y-o-Y) to Rs 2434.2 crore, according to ICICI Securities. Cadila to report net profit at 309.7 crore up 19.5% quarter-on-quarter.
Apr 17, 2017 01:13 PM IST Net Sales are expected to increase by 5.8 percent Q-o-Q (down 0.4 percent Y-o-Y) to Rs 2434.2 crore, according to ICICI Securities. Cadila to report net profit at 309.7 crore up 19.5% quarter-on-quarter.
Jan 14, 2017 02:22 PM IST Net Sales are expected to increase by 7.1 percent Q-o-Q (up 4.9 percent Y-o-Y) to Rs 2535.1 crore, according to ICICI Securities.
Jan 13, 2017 12:29 PM IST Net Sales are expected to increase by 7.5 percent Q-o-Q (up 7.3 percent Y-o-Y) to Rs 2512.6 crore, according to KR Choksey.
Oct 26, 2016 10:42 AM IST Pharma company Cadila Healthcare is expected to report a 2.3 percent growth in second quarter profit at Rs 399.83 crore and 0.7 percent rise in revenue at Rs 2,477.2 crore on yearly basis, according to average of estimates of analysts polled by CNBC-TV18.
Jul 16, 2016 01:15 PM IST Sales are expected to increase by 0.2 percent Q-o-Q (down 1.9 percent Y-o-Y) to Rs 2453.8 crore, according to Religare Research.
Jul 14, 2016 06:07 PM IST Net Sales are expected to increase by 3.4 percent Q-o-Q (up 4.3 percent Y-o-Y) to Rs 2532.4 crore, according to Edelweiss
May 13, 2016 09:30 AM IST During the quarter, EBITDA may increase 11 percent to Rs 551 crore compared to Rs 496 crore while operating profit margin may stand at 22 percent from 21.7 percent year-on-year.
